RMDA: The Pharma Growth Engine 💊🚀
The Driver: High-margin growth in chronic treatments.
Revenue hit EGP 3.95B with steady institutional backing. 📈💰
Sharia Status: ✅ Compliant. A stable member of the EGX33 Shariah Index. ☪️📜
The Valuation: Trades at a premium P/E (~21x), reflecting its faster expansion vs. peers. 💎📊
The Technicals:
the 3.79 EGP level (61.8% Fibonacci). This is the last line of defense for the medium-term bullish structure. 📏🛡️
If 3.79 fails, the price is likely headed for a "Mean Reversion" at the 200-day Moving Average (at 3.4). 🧲📉
The Risk: Vulnerable to API import costs and currency-driven margin squeezes. ⚠️🏗️
If you like my posts, please follow and boost 🙌
The Driver: High-margin growth in chronic treatments.
Revenue hit EGP 3.95B with steady institutional backing. 📈💰
Sharia Status: ✅ Compliant. A stable member of the EGX33 Shariah Index. ☪️📜
The Valuation: Trades at a premium P/E (~21x), reflecting its faster expansion vs. peers. 💎📊
The Technicals:
the 3.79 EGP level (61.8% Fibonacci). This is the last line of defense for the medium-term bullish structure. 📏🛡️
If 3.79 fails, the price is likely headed for a "Mean Reversion" at the 200-day Moving Average (at 3.4). 🧲📉
The Risk: Vulnerable to API import costs and currency-driven margin squeezes. ⚠️🏗️
If you like my posts, please follow and boost 🙌
Declinazione di responsabilità
Le informazioni e le pubblicazioni non sono intese come, e non costituiscono, consulenza o raccomandazioni finanziarie, di investimento, di trading o di altro tipo fornite o approvate da TradingView. Per ulteriori informazioni, consultare i Termini di utilizzo.
Declinazione di responsabilità
Le informazioni e le pubblicazioni non sono intese come, e non costituiscono, consulenza o raccomandazioni finanziarie, di investimento, di trading o di altro tipo fornite o approvate da TradingView. Per ulteriori informazioni, consultare i Termini di utilizzo.